Ticagrelor ib isethionate bosutinib inhibits the autophosphorylation of
Pay in 4 interest-free payments of $20.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Live Spec
Ticagrelor ib isethionate bosutinib inhibits the autophosphorylation ofTicagrelor, also known as AZD 6140 and AR C 126532XX, is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved in 2011. Ticagrelor is an antagonist of the P2Y12 receptor. Like the thienopyridines prasugrel, clopidogrel and ticlopidine, ticagrelor blocks adenosine diphosphate (ADP) receptors of subtype P2Y12. In contrast to the other antiplatelet drugs, ticagrelor has a binding site different from ADP, making it an allosteric
Store: lichtblickpflege-alltagsbegleiter.de · Domain: lichtblickpflege-alltagsbegleiter.de
